FOLH1 and neoplasm: Alternatively, Kloss et al. designed PSMA-specific, TGF-β-insensitive (dnTGF-βRII-T2A-Pbbz) CAR-T cells that exhibited increased proliferation, enhanced cytokine secretion, prolonged persistence, and induced tumor eradication (NCT03089203) [145].